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Abstract
Background: The local immune responses to chronic echinococcal infections in various organs are largely unknown.
Since the liver is the most frequently involved organ in such infections in human we aimed to characterize the
inflammatory as well as immune cell infiltrate around hydatid cysts in the liver and compared to common
inflammatory processes of the liver.
Method: Surgical samples from the liver of 21 cystic echinococcosis (CE) patients were studied and the distribution of
different types of inflammatory and immune cells were determined by immunohistochemistry. Furthermore,
expression levels of costimulatory CTLA4, CD28, CD80 and CD86 molecules were measured at RNA level by PCR.
Liver biopsy samples from patients with steatohepatitis (SH, n = 11) and chronic hepatitis (CH, n = 11) were used
as non-inflammatory and chronic inflammatory controls, respectively. The composition and density of the
inflammatory and immune cell infiltrates have been compared by using morphometry.
Results: CD3+ T cells predominated the inflammatory infiltrate in all pathological processes, while in CE samples
CD20+ B cells, in CH samples CD68+ macrophages were also frequent. Both myeloperoxidase (MPO) + leukocytes
and CD68+ macrophages were found to be significantly decreased in CE as compared to either SH or CH
samples. Concerning T cell subtypes, only CD8+ T cells were found to be significantly decreased in SH samples.
CD1a + dendritic cells were almost completely missing from CE biopsies unlike in any other sample types. There
were no differences detected in the mRNA expression of costimulatory molecules except decreased expression of
CD28 in CE samples.
Conclusion: In the hydatid lesions of the liver of chronic echinococcal infections T cell-mediated immunity
seems to be impaired as compared to other types of chronic inflammatory processes, suggesting an
immunosuppressive role for Echinococcus granulosus, which deserve further attentions.
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Background
Cystic echinococcosis (CE) is a globally distributed para-
sitic disease caused by the larval stage of Echinococcus
granulosus (Cestoda) [1]. In an intermediate host, the
larva (metacestode) can invade various organs where it
evolves into a unilocular, fluid-filled (hydatid) cyst [1, 2].
In humans and many other mammalian species, the liver
is the major site of CE involvement [2]. The infection in-
duces an immune imbalance on the hepatic tissue, lead-
ing to severe destruction of the architecture due to
intensive inflammatory infiltrates and formation of fibro-
sis [2]. It is mostly due to the persistent activation of im-
mune system which imposes unfavorable changes on
normal homeostasis of the organ, however the parasite
can usually evade the host defense and the infection be-
comes chronic [2].
Normal liver immune homeostasis is sustained by dif-
ferent cells which reside the organ [3]. Inflammatory re-
sponses to an injury are characterized by dynamic
changes in cellular architecture of the liver [3]. A widely
accepted scenario defines the role of T helper (Th) 1 cy-
tokines which induce classical activation of macrophages
(MΦs) and infiltration of non-resident polymorpho-
nuclear (PMN) cells in acute responses [4]. Chronic in-
flammation is associated with alternatively activated
MΦs by Th2 cytokines which result in transformation of
hepatic stellate cells (HSCs) and fibrosis [4, 5]. Regulatory
T cells (Treg), as resident cells with immunosuppressive
traits, may have role in maintaining the physiological sta-
bility of the organ [6]. Signaling pathway through CD80
(B7-1)/CD86 (B7-2)-CD28/CTLA4 costimulatory mole-
cules has been proposed to have a crucial role in regula-
tion of the T cell-mediated immunity [7, 8]. The modal
shift in cytokine profiles from Th1 to Th2 is known as a
hallmark of immune responses to tissue-dwelling hel-
minths [2, 9]. It may facilitate the parasite survival in the
host but results in chronic granulomatous reactions and
fibrosis [2]. Nevertheless, little is known about the ar-
rangement of resident and non-resident cells in chronic
responses to hydatid cyst in the human liver.
Characterization of inflammatory infiltrates in the
chronic CE has been assessed in only a few studies using
experimentally or naturally infected animals. Results of
these studies should be cautiously extended to humans
due to the primary impact of host-specificity on the in-
fection pathogenesis [10, 11]. Indeed, the parasite pro-
vokes less severe pathological alterations in its normal
hosts (mostly herbivores in both domestic and sylvatic
life cycles) than in incidental (humans) or aberrant (la-
boratory animals) hosts [11, 12]. Normal hosts also show
different susceptibility to the infection [13]. The existing
knowledge of human immune reactions to the chronic
CE has been merely derived from peripheral blood
mononuclear cells (PBMCs) assays and serological
measurements. Cytokine profiling analyses have illus-
trated a contradictory scheme of the T cell response as
concurrent activity of interleukin [4]-2, interferon gamma
(IFN-γ), tumor necrosis factor alpha (TNF-α), IL-4, IL-5,
IL-6 and IL-12 can be detected in patients [2, 14]. Results
of separated studies showed traceable levels of TNF-α,
IFN-γ, IL-4, IL-5, IL-6, IL-10, IL-12, IL-13, IL-16, IL-17A
and IL-18 in the sera of hydatid patients, although IL-6,
IL-17A and IFN-γ had impaired activity in those with re-
lapsed disease [15–17]. Serological methods may only in-
dicate the overall systemic immunity which can be
interfered by temporal changes and many factors such as
genetic traits, physiological status and immune respon-
siveness of the individual, as well as the presence of cross-
reactive immune components and the localization of the
cyst [16, 18–21]. Besides, Results of in vitro studies pro-
vide indirect evidence of the human immune response to
CE, which may differ under experimental conditions.
As an instance, exposure of human PBMCs to the para-
site specific antigen B and its recombinant subunit
prompted skewed Th2 and Th1 cytokines, respectively
[22–24]. Whereas, hydatid crude antigen induced ex-
pression of IL-4, IL-5, IL-6 and IFN-γ in PBMCs iso-
lated from patients and showed correlation with the
infection status [25–27]. Collectively, these findings
suggest the concomitant activation of Th1 and Th2 in
the chronic CE. The expression of IL-10 may indicate
the presence of Treg-mediated immunoregulatory mecha-
nisms [28, 29]. Such a presumption shows significant dis-
parities between hydatid-induced immune profiles and the
scenario of cellular activities in the liver chronic inflam-
mations, thus may not yet implicate the characteristics of
organ-specific cellular responses in chronic CE of the hu-
man liver.
It can be hypothesized that the cellular composition
of inflammatory infiltrates around the hydatid lesion in
the human liver is likely governed by intrinsic mecha-
nisms that are specific to the organ and are directly ac-
tivated in response to a massive amount of parasite
antigens, however it has not been accurately described
yet. Accordingly, this study was aimed to characterize
the cellular populations, which infiltrates the liver in
chronic human CE. An immunohistochemical analysis
was herein performed to quantify the inflammatory cell
infiltrates in liver biopsies of CE patient by using a
panel of mono/polyclonal antibodies against CD1a,
CD20, CD68, myeloperoxidase (MPO), smooth muscle
actin-α (α-SMA), CD3, CD4, CD8, and FOXP3. To
asses T cell mediated functions further at the periphery
of hydatid cyst, mRNA expression level of costimula-
tory molecules (CTLA4, CD28, CD80 and CD86) was
quantified by RT-PCR. CE patient cohort was compared
to those with steatosis (SH) and chronic inflammation
of the liver (CH).
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Methods
Patients and sample preparation
Formalin-fixed, paraffin-embedded tissue samples of the
liver from 21 surgically operated CE patients, 14 females
(66.7 %) and 7 males (33.3 %), between 5 to 79 years of
age were obtained from the archives of the 2nd Depart-
ment of Pathology at Semmelweis University, Budapest,
Hungary. All samples had been prepared from total or
subtotal pericystectomy materials showing cyst lumen,
fibrous capsule and liver parenchyma adjacent to the
parasitic lesion. Biopsies from 11 patients with CH, 4 fe-
males (36.4 %) and 7 males (63.6 %) between 2 months
to 63 years of age and 11 patients with SH, 7 males
(63.6 %) and 4 females (36.4 %) between 12 to 75 years
of age were also included. This study obtained licence
from the institutional review board of the Semmelweis
University (TUKEB15/2008).
Immunohistochemistry
Tissue sections of 2.5 μm thickness were prepared
using Thermo Scientific Finesse E+ microtome (Thermo
Scientific, Waltham, MA, USA). Some sections were
mounted on microscope slides and were stained by
hematoxylin-eosin method. Immunohistochemistry (IHC)
was performed by using BenchMark XT automated slide
preparation system (Ventana Medical Systems, Tucson,
AZ, USA) and assays were run by applying UltraView
DAB detection kit (Ventana Medical Systems). The kit
was optimized regarding an indirect IHC protocol which
was based on heat-induced epitope retrieval (HIER)
method, using citrate-EDTA buffer (10 mM citric-acid,
2 mM EDTA, 0.05 % Tween20, pH: 6.2) for unmasking
calcium ions-masked tissue and avidin/biotin solution for
reducing background or unspecific staining. 2,3-diamino-
benzidine, copper sulphate and hematoxylin II were used
as chromogen, post-chromogenic enhancement and coun-
terstain agents, respectively. All specimens were examined
with a panel of mono/polyclonal antibodies against
human cell surface markers corresponding designated
cell populations.
mRNA isolation and quantification
Total RNA was isolated using High-Pure RNA Paraffin
kit (Roche Diagnostics, Penzberg, Germany). TURBO
DNA-Free kit (Ambion, Austin, TX, USA) was used to
remove the contaminating DNA from subsequent iso-
lates. Elimination of DNA was controlled by a conven-
tional PCR optimized for amplification the housekeeping
gene β-actin, using 2 μl of each isolate mixed with
12.5 μl dNTPs/Taq polymerase (Fermentas Life Sciences,
Pittsburgh, PA, USA), 2.5–2.5 μl of the appropriate pri-
mer pair (0.5 μM), 0.5 μl MgCl2 and nuclease-free water
(nfH2O) to the total volume of 23 μl. Total RNA was re-
verse transcribed to cDNA with oligo-dT and random
hexamer primers using TaqMan reverse transcription re-
agents (Life Technologies, Carlsbad, CA, USA) as per
manufacturer’s instructions. In brief, 8 μl of purified
total RNA with 1 μl dNTP (10 mM) and 1 μl oligodT
and random hexamer were mixed and were incubated
for 10 min at 70 °C in a thermal cycler. Tubes were
chilled on ice for 2 min and 2 μl reverse transcriptase
buffer, 1 μl M-MLV reverse transcriptase and 0.5 μl
RNase inhibitor (all provided by M-MLV Reverse Tran-
scriptase Kit, SIGMA) with 6.5 μl nfH2O were added to
each tube. This procedure was continued by one hour
incubation at 37 °C in a thermal cycler and products
were tested by β-actin PCR for presence of cDNA. Pri-
mer pairs were designed specific for one splicing variant
(transcript variant 1 of each molecule mRNA sequence)
and oligonucleotides:
for CTLA4,
sense 5′-TGGCTTGCCTTGGATTTCAG-3′ and
antisense 5′-GGAATCATCTAGGAAGGTCAACTC-3′,
for CD28,
sense5′-AAGCATTACCAGCCCTATG-3′ and
antisense 5′-AGAGCAGTGATATTGAGCAGATG-3′,
forCD80,
sense5′-CCTGGTTGGAAAATGGAGAA-3′and
antisense5′-AGGAAAATGCTCTTGCTTGG-3′,
for CD86,
sense 5′-TGTCAGTGCTTGCTAACTTCAG-3′ and
antisense 5′-TGGTCATATTGCTCGTAACATCAG-3′,
were synthesized by Integrated DNA Technologies (IDT,
Coralville, IA, USA) upon order. The specificity of
primers was evaluated by employing a PCR (as above)
and amplified products were separated on a 3 % agarose
gel. After ethidium bromide staining, reactive bands
were visualized by a transluminator (Ultraviolet Light
Box, GBox, SYNGENE, Synoptic Group, UK) and then
were excised from the gel and cDNA was recovered by
using EZ-10 Speed Column DNA kit (Bio Basic, Ontario,
Canada). The DNA sequences were determined by Big-
Dye Terminator v1.1 Cycle Sequence kit (Applied Bio-
systems, Foster City, CA, USA), and were matched to
corresponding molecules by a BLAST search.
Real-Time PCR was carried out using iQ SYBR-Green
Supermix kit (Bio-Rad). All reactions were in triplicate
with cycling parameters as: 95 °C for 3 min, 50 cycles
(95 °C for 15 s, 56 °C for 30 s and 72 °C for 40 s),
followed by a melting curve rising from 56 to 95 °C and a
cooling cycle at 37 °C for 10 s. Starting quantities were
defined on the basis of standard fivefold dilution series
(1X-625X) were prepared with control cDNA of human
colon cancer (cell line A431, Molecular Pathology Lab, 2nd
Department of Pathology, Semmelweis University,
Budapest, Hungary) and all measurements were normalized
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with housekeeping β-actin (background gene) starting
quantities from the same cDNA samples. Standard error in
technical triplicate ranged from 0.9 to 3.0 % (average:
2.2 %) and nfH2O was used as the no-template control.
Data analysis
Results of IHC test were evaluated by applying a semi-
quantitative assessment: each slide was observed with a
light microscope for three times at x400 magnification
and about 10 fields were randomly selected in each
round. Thus, the number of immunolabeled cells was
counted in 30 fields under a fixed focus for each slide
and value of median for total count of each identified
cell phenotype was scored and assigned to groups as
follows:
Data were expressed as mean ± standard deviation
(SD) and Analysis of Variance (ANOVA) test was used
for differences between groups. Spearman’s rank correl-
ation coefficient (Rho) was calculated for dependence
between quantified mRNA level of costimulatory mole-
cules and corresponding immunostained cell phenotypes
in biopsy samples. Relative frequency (RF) of each cell
type was calculated as the mean ratio (%) of a cells
phenotype (mean) in total number of all counted cells
for each sample group. Values p < 0.05 were regarded as
statistically significant.
Results
Histology
Tissue damage and fibrosis were observed in all samples
obtained from CE patients. Inflammatory cell infiltrates
were detected in all CE samples around the fibrous cap-
sule mainly consisting of fibroblast-like cells along with
infiltrating lymphocytes, occasional polymorphonuclear
cells and monocytes. Hydatid cysts with partial calcifica-
tion were observed in 8 % (5 of 21) of patients. Due to
the presence of protoscolices or hooklets in histology
sections, cysts were identified as fertile in all patients.
Ductular proliferation and hydatid cyst rupture into bil-
iary tracts were observed in 4 patients (19 %) (Table 1).
Hepatocytes with large lipid droplets in their cytoplasm
were detected in all SH samples. Ductular reaction (n = 8,
73 %) and slight tissue remodeling and mild accumulation
of connective tissue fibers (n = 5, 45 %) were also observed
in some SH biopsies. Pericellular scar and septal fibrosis
along with macrovesicular steatosis and inflammatory
nodules were detected in 2 (18 %) SH patients. Iron stain-
ing demonstrated the present of hemosiderin in ~30 % of
Kupffer cells in these biopsies. Besides, apoptotic hepato-
cytes were observed among normal cells in the paren-
chyma. Histopathological examination of CH biopsies
showed a range of different alterations in the liver from
mild infiltration of inflammatory cells and slight remodel-
ing in the lobular structures of portal areas to septal fibro-
sis. Portal fibrosis was observed in 64 % (n = 7) of these
CH biopsies (Table 1).
Quantitative evaluation of inflammatory cell densities
In all CE biopsies, MPO+ cells were absent or were
scanty, localized mostly within sinusoidal spaces of the
liver. The density of these cells (Fig. 1) scattered within
inflammatory areas of the parenchyma in SH and CH
was higher than that in CE, although the statistical ana-
lysis only confirmed the significant difference between
CE and CH in this regard, p = 0.01 (Table 2).
T cells predominantly consisted of CD3+ cells in all
liver biopsies. These cells were mostly observed as
densely accumulated clusters around the pericyst in CE
biopsies. There was no significant difference between the
sample groups according to the number of labeled CD3+
T lymphocytes. In CE livers, CD4+ and CD8+ cells were
absent or had very low to low counts at the site of injury
characterized by small cellular clusters of adhered to the
pericystic adventitia as well as scattered cells throughout
the parenchyma. CE liver biopsies from 6 patients (29 %)
lacked CD8+ cells and the amount of these cells was
relatively moderate at the periphery of hydatid lesion in
two patients (9.5 %). There was no significant difference
according to the density CD8+ cells between CE and SH,
whereas such a value was found significantly higher in
CH biopsies, p = 0.02 (Fig. 2) (Table 2). Aggregation of
CD4+ T cells around the pericyst was scored as very low
to low (from 0 to max 67 cells/filed, mean: 29 ± 18.94
cells/field) with less disparity regarding the number of
infiltrated cells between individual samples and was not
significantly different than that in SH and CH biopsies.
Table 1 Pathology of the liver biopsies of patients with cystic echinococcosis (CE, n = 21), steatosis (SH, n = 11) and chronic hepatitis
(CH, n = 11)
Sample
Groups
Range of Age
(Year)
Sex Pathology
Male
(n)
Female
(n)
Intrabiliary Rupture
(n)
Portal Fibrosis
(n)
Periportal Fibrosis
(n)
Septal Fibrosis
(n)
Ductular Reaction
(n)
CE 41 ± 19.31 7 14 4 10 2 1 -
SH 26 ± 22.31 7 4 - 5 - 2 8
CH 26 ± 19.31 7 4 - 7 - 1 7
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Cells with FOXP3+ phenotypes were absent or had very
low score in all sample groups (Table 2).
B lymphocytes comprised the second largest cellular
population and were identified by expression of CD20
surrounding the hydatid lesion. The amount of CD20+
cells quantified in CE livers was higher than SH and CH,
however this difference was not statistically significant.
In all samples, these cells formed focally aggregated clus-
ters adjacent to the scar tissue. Number of CD68+ cells
was found highly variable in CE livers, ranged from 0 (in
one sample) to ≥500 (in two samples). The density of
CD68+ macrophages in the inflammatory infiltrate of
CH livers was significantly higher than that in CE and
SH samples, p < 0.001 (Fig. 1) (Table 2).
Rare scattered CD1a+ cells were observed throughout
the parenchyma SH (13 ± 11.85 cells/field) and CH (8 ±
9.63 cells/field) livers, whereas they were completely ab-
sent in CE biopsies (Fig. 2). No difference was found be-
tween SH and CH regarding the number of CD1a+ cells
in the inflammatory milieu of the liver (Fig. 2) (Table 2).
Among the perihydatid cells α-SMA+ myofibroblasts
were the most frequent cell type constituted the non-
parenchymal cell population in all biopsies. Relative fre-
quency of these cells was higher in CE and SH than that
A B
C D
Fig. 1 Localization of leukocytes and macrophages in liver biopsies. a/b Localization of neutrophil leukocytes as detected by MPO
immunohistochemistry in CH (a) and CE (b) samples. Note the decreased density in CE biopsy. c/d Localization of macrophages by CD68
immunchemistry in CH (c) and CE (d) biopsies. Note the significant infiltration of macrophages in CH (c) and decreased presence in CE sample
(d). Bar: 100 μm
Table 2 Density of inflammatory cells of the liver in cystic echinococcosis, steatosis and chronic hepatitis biopsy samples
CE SH CH p Value
Marker Cells/field (mean ± SD) Cells/field (mean ± SD) Cells/field (mean ± SD) CE vs. SH CE vs. CH SH vs. CH
CD1a 0 ± 1.1 13 ± 11.85 8 ± 9.63 0.00001 0.006 0.5
CD3 265 ± 138.66 232 ± 198.11 241 ± 143.89 0.9 0.9 0.9
CD4 29 ± 18.94 24 ± 22.86 57 ± 46.16 0.1 0.1 0.1
CD8 20 ± 50.61 17 ± 26.62 36 ± 23.27 1 0.02 0.1
FOXP3 4 ± 4.53 10 ± 8.64 20 ± 29.87 0.1 0.1 0.1
CD20 230 ± 174.86 50 ± 53.78 140 ± 128.50 0.06 0.06 0.06
CD68 101 ± 147.13 108 ± 77.47 258 ± 107.82 1 0.0006 0.05
MPO 35 ± 30.89 65 ± 28.82 133 ± 118.14 0.06 0.01 1
α-SMA 537 ± 75.63 394 ± 104.19 364 ± 130.97 0.001 0.001 1
Data are mean number of immunostained cells (M) ± SD in CE (cystic echinococcosis), SH (Steatosis), and CH (chronic hepatitis) biopsies as determined in
Materials and Methods section. Value of significance (p) has been exhibited for differences between sample groups in pair
MPO Myeloperoxidase (presented in bold)
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in CH, p ≤ 0.05. There was no significant difference be-
tween CE and SH groups according to the relative fre-
quency of CD68+ cells in inflammatory infiltrates of the
liver, but this value was significantly higher in CH sam-
ples, p < 0.05. On the contrary, CD20+ cells showed the
highest frequency in CE compared to SH and CH, p <
0.05. Altogether, CD3+ T lymphocytes were the most
frequent subtype of T cells and showed similar pattern
in all biopsies. Other activation markers of T cells were
detected on much smaller proportion of infiltrated cells
within inflammatory regions of the liver in all groups
(Fig. 2).
Expression level of costimulatory molecules
Antigen presenting cells associated costimulatory mole-
cules (CD80-CD86) had high expression level in all bi-
opsies. The expression of CD80 and CD86 at the mRNA
level in CH biopsies was slightly higher than other two
groups but differences were not significant (Table 3)
(Fig. 3). CTLA4 was highly expressed at the mRNA level
in CH livers that showed 435-fold and 73-fold increase
compared to CE and SH, respectively. Expression level
of CTLA4 in SH was also higher (6-fold) than CE. How-
ever the average level of CTLA4 expression was not sig-
nificantly different between all groups more likely due to
the wide range of inter-sample variations. Expression of
CD28 had a remarkable decrease in CE livers compared
to other sample groups and such a difference was statis-
tically significant (SH/CE = 2171 fold, p = 0.0001), (CH/
CE = 6191 fold, p < 0.00001) (Table 3).
The ratio of CD28/CTLA4 in CE samples was 0.3
showing a slightly higher prevalence of CTLA4 expres-
sion around the hydatid lesion. Such a ratio in CH sam-
ples was found to be 4, and was the highest (CD28/
CTLA4 = 93) in SH biopsies. On the other hand, the
level of CD80 mRNA was higher than CD86 at CD80/
Table 3 mRNA expression levels of costimulatory molecules in inflammatory infiltrates of the liver in cystic echinococcosis, steatosis
and chronic hepatitis biopsy samples
Costimulatory
Molecules
CE SH CH P Value
Mean ± SD Mean ± SD Mean ± SD CE vs SH CE vs CH SH vs CH
CTLA4 0.073 ± 0.099 0.182 ± 0.233 5.293 ± 16.949 0.1 0.07 0.1
CD28 0.087 ± 0.018 24.361 ± 22.860 71.128 ± 60.365 0.0001 <0.00001 0.1
CD80 50.779 ± 67.682 54.731 ± 74.778 67.712 ± 98.575 0.5 0.1 0.5
CD86 61.528 ± 117.973 27.526 ± 33.573 62.451 ± 89.896 0.2 0.5 0.5
Expression of costimulatory molecules was quantified by calculating the ratio of target mRNA level to a background houskeeping β-actin mRNA and was defined
as mean ± SD for three sample groups: cystic echinococcosis (CE), steatosis (SH) and chronic hepatitis (CH) (presented in bold)
A B
C D
Fig. 2 Localization of cytotoxic T cells and dendritic cells in liver biopsies. a/b Identification of cytotoxic T cells by CD8 immunohistochemistry in
CH (a) and CE (b) samples. Note the significant portal and lobular presence of CD8 + T cells in CH (c) and a decreased infiltration in CE sample
(b). c/d Identification of dendritic cells in liver biopsies using CD1a immunohistochemistry. Note the complete absence of CD1a + cells in CE (d)
as compared to CH (c) sample. Bar: 100 μm
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CD86 ratios of 1 and 2 in SH and CE, respectively, but
this ratio reversed in CH biopsies (CD80/CD86 = 0.7).
Expression of CTLA4 and CD28 had no significant
correlation with the density of various phenotype
markers (CD3+, CD4+, CD8+, and FOXP3+) in CE and
SH samples. In CH livers, expression of CTLA4 was
positively correlated with the quantity of CD4+ cells in
each individuals, Rho = 0.664, p = 0.03 (Fig. 3).
A
B
C
Fig. 3 Correlation between quantity of CD4+T cells and mRNA expression level of costimulatory CTLA4 molecule in liver samples. a = CE, b = SH,
c = CH biopsies. Statistical analysis identified only significant correlation between the two factors in CH samples (c)
Vatankhah et al. BMC Infectious Diseases  (2015) 15:530 Page 7 of 12
Expression of CD80 and CD86 measured in CE
and CH livers was significantly correlated each other
(Rho = 0.525, p = 0.01 and Rho = 0.755, p = 0.007, re-
spectively), while this correlation was not significant
in SH (Fig. 4).
Discussion
Our data indicated an overall impairment of T cell activ-
ities in the liver of patients with chronic CE. As novel
data, we have shown the expression pattern of costimula-
tory molecules in the inflammatory infiltrate surrounding
A
B
C
Fig. 4 Correlation between CD86 and CD80 mRNA expression levels in liver biopsies. Statistical analysis identified significant correlation in CE (a)
and CH (c) samples where no such correlation was detected in SH materials (b)
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chronic hydatid lesions in human liver. According to our
results, the expression of CTLA4 mRNA was very low in
all sample groups. Similarly, CD28 mRNA had a signifi-
cantly lower level in CE than that in SH and CH. Signal
transduction through CD28, which is constitutively
expressed on both CD4+ and CD8+ subtypes, is essential
for the T cell activation [7]. To reduce the magnitude of
immune reactions, some CD4+ T cells express CTLA4
which has downregulatory effect on CD28 [30]. The func-
tion of CTLA4 is associated with the Treg cells activity and
its presence is dependent on expression of FOXP3 [30].
The expression of CTLA4 mRNA was significantly corre-
lated with the presence of CD4+ cells only in CH biopsies;
however this correlation between CTLA4 and FOXP3 was
insignificant in all sample groups. The phenotypic change
of T cells to CD28− subtypes has been reported in infec-
tions, autoimmune diseases and cancer [31–34]. The role
of costimulatory molecules in CE has been barely defined,
but hydatid fluid antigen seems to induce diminished ex-
pression of CD28 in T cell cultures [35]. Insignificant ex-
pression of CD28 and CTLA4 mRNA measured in this
study could suggest the poor activity of T cell-dependent
mechanisms at the periphery of hydatid cyst in human
chronic infection, probably due to the clonal deletion of
specifically activated T cells [36].
Immunohistochemistry also revealed that CD3+ cells
were the most frequent T cells infiltrated the inflamma-
tory milieu of the liver in all sample groups. In contrast,
CD4+ and CD8+ subpopulations were significantly out-
numbered at the periphery of hydatid lesions in CE bi-
opsies at a CD4+/CD8+ ratio of 10.30. This ratio was
0.85 and 1.29 for SH and CH biopsies, respectively. T
cells dominated by the CD3+ subtype reported in the
pericystic adventitia of the hepatic cysts in sheep, while
CD8+ and CD4+ cells were the most frequent popula-
tions in cattle with progressive and regressive cysts, re-
spectively [29, 37]. Intriguingly, 40–70 % of cysts in
humans and sheep are fertile, while 70–100 % of cysts in
cattle have degenerated or undeveloped structures [38–
42]. Altogether these findings along with outcomes of
the present study suggest the impact of the host suscep-
tibility of the composition of T lymphocytes which are
locally activated in response to the liver hydatid infec-
tion. Besides, the density of CD8+ cells was found to be
different in three sample groups. Although such a differ-
ence was not significant between CE and SH, it could
imply the prognostic value of CD8-dependent T lympho-
cyte activity in chronic inflammations of the liver with
different etiology. Presumably, predominance of CD3+ im-
munostained cells with weak presence of CD4+ and CD8+
subtypes in CE biopsies also highlighted the role CD3
+CD56+ natural killer T cells in the hydatid-induced
chronic inflammation of the liver, which is worth further
investigation [43].
Abundant number of B cells expressing CD20 ob-
served at the periphery of hydatid lesions, demonstrated
significant activity of adaptive immune system. In nor-
mal conditions, B cells comprise a very low proportion
of the liver resident cells, but they infiltrate the paren-
chyma during the inflammatory response [44]. The
humoral immune response to hydatid cyst in human has
been studied by applying indirect measurements [2].
Therefore, our data could denote the importance of B
cells in immune functions which are locally activated
against the parasite in the liver.
Furthermore, results of this study demonstrated the
inadequate involvement of PMN cells and MΦs in
chronic responses to CE in the human liver. Evidently, the
antibody-dependent cell mediated cytotoxicity (ADCC) is
an important defense mechanism primarily activated
against the chronic phase of helminth infections [2]. Dur-
ing the early phase of infection, type 1 cytokines classically
activate MΦs, in case of the liver resident ones such as
Kupffer cells as well, that in turn recruit neutrophils and
other leukocytes by expression of various immune media-
tors [2, 45]. As a consequence, an acute inflammation is
initiated which induces overproduction of toxic radicals
[2]. Expression of inducible nitric oxide synthase (iNOS) is
enhanced via activation of proinflammatory cytokines
such as IFN-γ, IL-1β and TNF-α that causes the release of
nitrite free radicals, however may perpetuates parenchy-
mal damage by inducing apoptosis [46]. A specific hydatid
antigen (antigen 5) has been shown to induce production
of nitric oxide and IFN-γ in PBMC cultures derived from
hydatid patients [47]. Immunohistochemical detection of
iNOS in liver biopsies and its significant levels in the sera
as well as in hydatid fluid have been also reported in CE
patients [47]. On the other hand, Th2-like cytokines such
as IL-4, IL-5 and IL-13 are predominant in immune re-
sponses to the chronic phase of infection which induce al-
ternative activation of MΦs and upregulate the ADCC
response [9]. Conceptually, tissue-dwelling helminths
should employ mechanisms by which they can diminish
ADCC-related inflammatory responses to prolong their
survival within the host tissue [9]. Study showed that
some antigenic compounds of the parasite reduce neutro-
phil activation in vitro [22, 48]. Results achieved by the
current study also confirmed that CD68+ MΦ and MPO+
neutrophils weakly infiltrate the liver parenchyma
surrounding the cyst in chronic infection. Nonetheless,
largely impaired activities of FOXP3+ and CD4+ cells
along with insignificant expression of CTLA4 mRNA in
CE biopsies could suggest that underlying mechanisms, by
which the parasite mediates the long-lasting suppression
of immune responses in the human liver, are probably T
cell-independent. It could imply the immune inhibitory
properties of parasite antigens that may directly affect the
inflammatory cell activation around the pericyst.
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In contrast to T cell costimulatory proteins, molecular
assay indicated the remarkable levels of CD80 and CD86
mRNA in the CE biopsies as well as in the other sample
groups. These molecules are constitutively expressed on
the surface of DCs, as professional antigen presenting
cells, but can be also seen on MΦs and B cells upon
stimulation [49]. Resting DCs express CD86 at higher
level than CD80, but the expression of both molecules is
enhanced following activation [49]. They share the same
ligands on the surface of T cells and it is conventionally
believed that CD80/CD86-CD28 engagement transduces
the secondary activation signal. Expression of CTLA4 is
augmented on activated T cells and this molecule binds
to the same ligands with higher affinity and delivers in-
hibitory signal [49]. Recent studies, however, have
indicated that signal transduction through CD86 may
enhance the immune response but CD80 conducts im-
munosuppressive signals [49, 50]. Therefore, the imbal-
ance between CD86 and CD80 can be an indicator for
pathogenesis of inflammatory diseases, as it has been
described elsewhere [51]. In CE and CH samples, the
expression of CD80 and CD86 at the mRNA level was
positively correlated, indicating the continuous activa-
tion of antigen presenting function and a chronic in-
flammation. Perhaps, the absence of CD1a+ cells in the
pericystic adventitia represented the participation of spe-
cific DC phenotypes in hydatid-induced inflammation of
the liver. In human, heterogeneous lineages of DCs com-
prising CD1a+ and CD1a− subsets have been identified
in different compartment such as peripheral blood [52].
Myeloid DCs express CD1a in response to type 1 cyto-
kines, but evolve into CD1a− subtypes in absence of ex-
ogenous mediators in vitro [53]. CD1a+ DCs produce
significant amount of IL-12 and can polarize naïve T cell
to Th1 [54]. The involvement of DCs in immunopathol-
ogy of chronic CE has not been thoroughly studied yet.
The only available data show the ability of parasite anti-
gens to induce alternative differentiation of murine and
human DCs in vitro, which results in overproduction of
CD86 and downregulation of CD1a and their enhanced
ability to activate Th2 or Treg responses [23, 55–57].
Altogether, results of the present study could also imply
the crucial role of DCs in the tissue-specific immune
response in human chronic CE of the liver. These results
may also highlight the contribution of distinctive DC
subtypes in the hydatid-induced chronic inflammation of
the liver, which needs further investigation.
Finally, an excessive accumulation of α-SMA+ cells
and consequent fibrosis in the immediate vicinity of
hydatid cyst in all CE samples, showed the presence of
continous wound-healing processes. It could be chal-
lenged by the inefficient activity of inflammatory cells
around the pericyst, which was detected in this study.
Additionally, a contribution of B cells to the formation
of liver fibrosis cannot be excluded [58, 59]. It is further
future issue, whether hydatid antigens can directly medi-
ate liver fibrosis, as it has been implied in other hel-
minth infections such as schistosomiasis [60].
Conclusion
This is the first comprehensive analysis of the inflamma-
tory infiltrates of the chronic echinococcal infection of
human liver. Our study indicated an attenuated cell-
mediated immunity and diminished activation of various
T cell phenotypes in infected liver. The complete ab-
sence of CD1a + DC cells and the presence of a signifi-
cant amount of B cells could hallmark the essential role
of APCs, more likely DCs with CD1a− phenotype [28], in
regulation of homeostatic changes and tissue-dependent
responses [29] that result in distinctive immunopathology
of CE in the human liver. Further studies with larger
number of samples are necessary to clarify the function of
recruited or resident effector cells involved in the liver
immune reactions against chronic CE.
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